Long Yuan

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Squamous Cell Carcinoma

Top Venues

Cancer research

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Shuming Zhang, Atul Deshpande, Babita K Verma, Hanwen Wang, Haoyang Mi, Long Yuan, Won Jin Ho, Elizabeth D Thompson, Qingfeng Zhu, Robert A Anders, Mark Yarchoan, Luciane Tsukamoto Kagohara, Elana J Fertig, Aleksander S Popel
Integration of Clinical Trial Spatial Multi-omics Analysis and Virtual Clinical Trials Enables Immunotherapy Response Prediction and Biomarker Discovery. Cancer research (2024)
Shuming Zhang, Atul Deshpande, Babita K Verma, Hanwen Wang, Haoyang Mi, Long Yuan, Won Jin Ho, Elizabeth D Thompson, Qingfeng Zhu, Robert A Anders, Mark Yarchoan, Luciane Tsukamoto Kagohara, Elana J Fertig, Aleksander S Popel
Integration of Clinical Trial Spatial Multi-omics Analysis and Virtual Clinical Trials Enables Immunotherapy Response Prediction and Biomarker Discovery. Cancer research (2024)
Shuming Zhang, Atul Deshpande, Babita K Verma, Hanwen Wang, Haoyang Mi, Long Yuan, Won Jin Ho, Elizabeth D Thompson, Qingfeng Zhu, Robert A Anders, Mark Yarchoan, Luciane Tsukamoto Kagohara, Elana J Fertig, Aleksander S Popel
Integration of Clinical Trial Spatial Multiomics Analysis and Virtual Clinical Trials Enables Immunotherapy Response Prediction and Biomarker Discovery. Cancer research 84 (16) (2024)
Shuming Zhang, Atul Deshpande, Babita K Verma, Hanwen Wang, Haoyang Mi, Long Yuan, Won Jin Ho, Elizabeth D Thompson, Qingfeng Zhu, Robert A Anders, Mark Yarchoan, Luciane Tsukamoto Kagohara, Elana J Fertig, Aleksander S Popel
Integration of Clinical Trial Spatial Multiomics Analysis and Virtual Clinical Trials Enables Immunotherapy Response Prediction and Biomarker Discovery. Cancer research 84 (16) (2024)
Kathleen M Mahoney, Petra Ross-MacDonald, Long Yuan, Linan Song, Eliseo Veras, Megan Wind-Rotolo, David F McDermott, Frank Stephen Hodi, Toni K Choueiri, Gordon J Freeman
Soluble PD-L1 as an early marker of progressive disease on nivolumab. Journal for immunotherapy of cancer 10 (2) (2022)